Skip to content
  • Insights Newsletter

    Always Be a Step Ahead

    Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

    Subscribe to AMI's Insights Newsletter Today.

     

  • Login
  • Contact
  • Subscribe
  • Insights Newsletter

    Always Be a Step Ahead

    Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

    Subscribe to AMI's Insights Newsletter Today.

     

  • Login
Access Market IntelligenceAccess Market Intelligence
  • Menu
  • About
    • Dr. Randy Vogenberg
    • John Santilli
    • News Announcements
    • Contact
  • Shop Reports
    • Filter By
      • Discounted
      • Latest Releases
    • Report Topic or Type
      • Ebooks
      • Provider Trends
      • Payor Trends
      • Purchaser Trends
      • Market Access & Distribution
  • Solutions
    • Data and Intelligence Platforms
      • Employer Sales Initiatives
    • Advisory and Consulting Services
      • Virtual Advisory Board for Healthcare
      • Strategy Development
      • Health Benefit Training
      • Custom Market Research
    • Specialty Pharmacy Database
  • Resources
    • Insights Blog
    • Sample Reports
    • Free Publications
  • Specialty Pharmacy Database
    • Blog – Specialty Pharmacy
    • SPD Case Study
    • SPD Request for Information
  • $0.00 0
    • No products in the cart.

  • Shop
  • 0

    Cart

    No products in the cart.

Tag Archives: Duchenne Muscular Dystrophy

Specialty Drug, Specialty Pharmacy, Uncategorized

Anovo Selected as Exclusive Distributor and Specialty Pharmacy for AGAMREE®

Posted on November 6, 2023 by John Santilli
06
Nov

Anovo was selected to work with Catalyst as the exclusive distributor and specialty pharmacy for FDA-approved AGAMREE®.

Continue reading →
Posted in Specialty Drug, Specialty Pharmacy, Uncategorized  |  Tagged 3PL, AGAMREE, Catalyst Pharmaceuticals, corticosteroid treatment, DMD, Duchenne Muscular Dystrophy, exclusive distributor, exclusive specialty pharmacy, FDA, FIRDAPSE, neuromuscular, patient care, rare disease, Santhera, Santhera Pharmaceuticals
Specialty Drug, Specialty Pharmacy

Duchenne Muscular Dystrophy (DMD) Patients Have Choice of Medications

Posted on November 9, 2020 by John Santilli

The number of chronic infusion therapies for neuromuscular disorders continues to grow

Continue reading →
Posted in Specialty Drug, Specialty Pharmacy  |  Tagged Accelerated Approval, DMD, DMD gene, Duchenne Muscular Dystrophy, dystrophin, exon 53, Exondys 51, FDA, genetic, golodirsen, neurological disorder, neurology, NS Pharma, Option Care, Option Care Health, Orsini, Orsini Healthcare, Orsini Pharmaceutical, Sarepta, Viltepso, Vyondys 53, X chromosome

Copyright 2023 © Access Market Intelligence. All Rights Reserved  |  Terms of Service 

  • Login
  • Home
  • Reports
    • View Samples
    • What’s New
    • On Sale
    • eBooks
    • By Market
      • Payor
      • Purchaser
      • Provider
      • Market Access & Distribution
  • Services
    • Virtual Advisory Board
    • Strategy Development
    • Health Benefit Training
    • Market Research
  • Data Solutions
    • Specialty Pharmacy Database (SPD)
    • Employer Sales Initiatives
  • Resources
    • Blog
    • Free Downloads
  • About
    • Contact

Login

Lost your password?

Register